首页> 美国卫生研究院文献>Molecular Cellular Proteomics : MCP >Cyclic AMP Analog Blocks Kinase Activation by Stabilizing Inactive Conformation: Conformational Selection Highlights a New Concept in Allosteric Inhibitor Design
【2h】

Cyclic AMP Analog Blocks Kinase Activation by Stabilizing Inactive Conformation: Conformational Selection Highlights a New Concept in Allosteric Inhibitor Design

机译:环状AMP模拟物通过稳定非活性构象来阻止激酶激活:构象选择突出了变构抑制剂设计的新概念

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The regulatory (R) subunit of protein kinase A serves to modulate the activity of protein kinase A in a cAMP-dependent manner and exists in two distinct and structurally dissimilar, end point cAMP-bound “B” and C-subunit-bound “H”-conformations. Here we report mechanistic details of cAMP action as yet unknown through a unique approach combining x-ray crystallography with structural proteomics approaches, amide hydrogen/deuterium exchange and ion mobility mass spectrometry, applied to the study of a stereospecific cAMP phosphorothioate analog and antagonist((Rp)-cAMPS). X-ray crystallography shows cAMP-bound R-subunit in the B form but surprisingly the antagonist Rp-cAMPS-bound R-subunit crystallized in the H conformation, which was previously assumed to be induced only by C-subunit-binding. Apo R-subunit crystallized in the B form as well but amide exchange mass spectrometry showed large differences between apo, agonist and antagonist-bound states of the R-subunit. Further ion mobility reveals the apo R-subunit as an ensemble of multiple conformations with collisional cross-sectional areas spanning both the agonist and antagonist-bound states. Thus contrary to earlier studies that explained the basis for cAMP action through “induced fit” alone, we report evidence for conformational selection, where the ligand-free apo form of the R-subunit exists as an ensemble of both B and H conformations. Although cAMP preferentially binds the B conformation, Rp-cAMPS interestingly binds the H conformation. This reveals the unique importance of the equatorial oxygen of the cyclic phosphate in mediating conformational transitions from H to B forms highlighting a novel approach for rational structure-based drug design. Ideal inhibitors such as Rp-cAMPS are those that preferentially “select” inactive conformations of target proteins by satisfying all “binding” constraints alone without inducing conformational changes necessary for activation.
机译:蛋白激酶A的调节(R)亚基以依赖cAMP的方式调节蛋白激酶A的活性,并以两种不同且结构上不同的端点cAMP结合的“ B”和C-亚基结合的“ H”形式存在”构象。在这里,我们通过结合x射线晶体学与结构蛋白质组学方法,酰胺氢/氘交换和离子迁移质谱的独特方法报告了cAMP作用的机制细节,该方法用于研究立体特异性cAMP硫代磷酸酯类似物和拮抗剂(( Rp)-cAMPS)。 X射线晶体学显示B形式的cAMP结合的R亚基,但是令人惊讶的是,以H构象结晶的拮抗剂Rp-cAMPS结合的R亚基,以前被认为仅由C亚基结合诱导。 Apo R亚基也以B形式结晶,但酰胺交换质谱法显示R亚基的apo,激动剂和拮抗剂结合状态之间存在很大差异。进一步的离子迁移率揭示了载脂蛋白R亚基为多种构象的集合,其碰撞截面积跨越了激动剂和拮抗剂结合状态。因此,与较早的研究仅通过“诱导适合”解释了cAMP作用的基础相反,我们报道了构象选择的证据,其中R亚基的无配体载脂蛋白形式同时存在于B和H构象中。尽管cAMP优先结合B构象,但Rp-cAMPS有趣地结合H构象。这揭示了环磷酸酯的赤道氧在介导从H到B形式的构象转变中的独特重要性,从而突出了基于合理结构的药物设计的新方法。理想的抑制剂(例如Rp-cAMPS)是那些通过单独满足所有“结合”约束条件而优先选择“选择”靶蛋白无活性构象的抑制剂,而不会引起激活所必需的构象变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号